Araştırma
Eğitim
Çözümler
Oturum Aç
TR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Atherothrombosis and Vascular Biology
Karlheinz Peter has not added Biography.
If you are Karlheinz Peter and would like to personalize this page please email our Author Liaison for assistance.
Mesoscale Nanoparticles: An Unexpected Means for Selective Therapeutic Targeting of Kidney Diseases!
Hypertension (Dallas, Tex. : 1979) 01, 2018 | Pubmed ID: 29133359
A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense.
Nature communications 02, 2018 | Pubmed ID: 29410422
Dual-Targeted Theranostic Delivery of miRs Arrests Abdominal Aortic Aneurysm Development.
Molecular therapy : the journal of the American Society of Gene Therapy 04, 2018 | Pubmed ID: 29525742
Baker Heart & Diabetes Institute
Monash University
Tatjana Michel1,
Antonia Link1,
Meike-Kristin Abraham1,2,
Christian Schlensak1,
Karlheinz Peter2,3,
Hans-Peter Wendel1,
Xiaowei Wang2,3,
Stefanie Krajewski1
1Department of Thoracic and Cardiovascular Surgery, Clinical Research Laboratory, University Medical Center,
2Atherothrombosis and Vascular Biology, Baker Heart & Diabetes Institute,
3Department of Medicine, Monash University
Gizlilik
Kullanım Şartları
İlkeler
Bize Ulaşın
KÜTÜPHANEYE TAVSİYE ET
JoVE HABER BÜLTENLERİ
JoVE Journal
Yöntem Koleksiyonları
JoVE Encyclopedia of Experiments
Arşiv
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Fakülte Kaynak Merkezi
Yazarlar
Kütüphaneciler
Erişim
JoVE Hakkında
Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır